Aprogen Pharmaceuticals Inc (003060) — Strategic Asset Allocation Index
Aprogen Pharmaceuticals Inc (003060) has a Strategic Asset Allocation Index of 3.0% as of September 2022. Strategic assets (PP&E of ₩18.38 Billion plus long-term investments of ₩-) total ₩18.38 Billion, measured against net assets of ₩604.45 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See debt-free asset ratio of Aprogen Pharmaceuticals Inc to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Aprogen Pharmaceuticals Inc Strategic Asset Allocation Index (2009–2021)
This chart shows how Aprogen Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 14 annual periods from 2009 to 2021. As of September 2022, the index stands at 3.0%, representing strategic assets of ₩18.38 Billion against net assets of ₩604.45 Billion KRW. For live market cap and overall valuation, see 003060 company net worth.
Annual Strategic Asset Allocation Index for Aprogen Pharmaceuticals Inc (2009–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Aprogen Pharmaceuticals Inc from 2009 to 2021, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Aprogen Pharmaceuticals Inc book value and equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 3.2% | ₩18.86 Billion | ₩18.86 Billion | ₩- | ₩597.18 Billion | ▼ -0.2 pp |
| 2020 | 3.3% | ₩19.80 Billion | ₩19.80 Billion | ₩- | ₩598.36 Billion | ▼ -36.4 pp |
| 2019 | 39.7% | ₩137.87 Billion | ₩45.91 Billion | ₩91.97 Billion | ₩347.64 Billion | ▼ -43.3 pp |
| 2018 | 82.9% | ₩124.85 Billion | ₩17.33 Billion | ₩107.52 Billion | ₩150.51 Billion | ▼ -21.1 pp |
| 2017 | 104.1% | ₩81.05 Billion | ₩18.16 Billion | ₩62.88 Billion | ₩77.86 Billion | ▲ +59.1 pp |
| 2016 | 45.0% | ₩35.16 Billion | ₩25.95 Billion | ₩9.21 Billion | ₩78.12 Billion | ▲ +6.4 pp |
| 2015 | 38.6% | ₩26.13 Billion | ₩25.11 Billion | ₩1.02 Billion | ₩67.75 Billion | ▼ -8.0 pp |
| 2014 | 46.6% | ₩28.91 Billion | ₩22.59 Billion | ₩6.33 Billion | ₩62.11 Billion | ▼ -1.0 pp |
| 2013 | 47.5% | ₩26.88 Billion | ₩21.20 Billion | ₩5.69 Billion | ₩56.55 Billion | ▲ +29.2 pp |
| 2012 | 18.3% | ₩12.54 Billion | ₩12.54 Billion | ₩- | ₩68.51 Billion | ▼ -8.8 pp |
| 2011 | 27.1% | ₩19.90 Billion | ₩19.90 Billion | ₩- | ₩73.49 Billion | ▼ -26.7 pp |
| 2010 | 53.8% | ₩23.02 Billion | ₩23.02 Billion | ₩- | ₩42.81 Billion | ▲ +29.6 pp |
| 2010 | 24.2% | ₩10.02 Billion | ₩10.02 Billion | ₩- | ₩41.38 Billion | ▼ -1.5 pp |
| 2009 | 25.7% | ₩6.47 Billion | ₩6.47 Billion | ₩- | ₩25.18 Billion | — |